1. Novel dinuclear gold(i) complexes containing bis(diphenylphosphano)alkanes and (biphenyl-2-yl)(di-tert-butyl)phosphane: synthesis, structural characterization and anticancer activity
   Adam A. A. Sulaiman et al, 2022, New Journal of Chemistry CrossRef
2. Auranofin sensitizes breast cancer cells to paclitaxel mediated cell death via regulating FOXO3/Nrf2/Keap1 signaling pathway
   N. Deepika et al, 2024, Cell Biochemistry and Function CrossRef
3. Dual inhibition of thioredoxin reductase and proteasome is required for auranofin-induced paraptosis in breast cancer cells
   Min Ji Seo et al, 2023, Cell Death & Disease CrossRef
4. Mitochondrial adaptation in cancer drug resistance: prevalence, mechanisms, and management
   Ping Jin et al, 2022, Journal of Hematology & Oncology CrossRef
5. Design, Synthesis, and Preclinical Activity in Ovarian Cancer Models of New Phosphanegold(I)-N-heterocyclic Carbene Complexes
   Adam A. A. Sulaiman et al, 2022, Journal of Medicinal Chemistry CrossRef
6. Synthesis, chemical characterization, and biological evaluation of a novel auranofin derivative as an anticancer agent
   Damiano Cirri et al, 2022, Dalton Transactions CrossRef
7. Cetuximab-conjugated PLGA nanoparticles as a prospective targeting therapeutics for non-small cell lung cancer
   Leena Kumari et al, 2023, Journal of Drug Targeting CrossRef
8. Protective Mechanism of Lycium barbarum Polysaccharide (LBP) on H2O2-Induced Apoptosis of Human Epithelium Retinal Pigment Cells
   Qianqian Hu et al, 2024, Journal of Biobased Materials and Bioenergy CrossRef
9. Comprehensive review of the repositioning of non-oncologic drugs for cancer immunotherapy
   Abdur Rauf et al, 2024, Medical Oncology CrossRef
10. Synthesis, Characterization, and Anticancer Activity of Phosphanegold(i) Complexes of 3-Thiosemicarbano-butan-2-one Oxime
    Sani A. Zarewa et al, 2023, Biomedicines CrossRef
11. Auranofin Induces Lethality Driven by Reactive Oxygen Species in High-Grade Serous Ovarian Cancer Cells
    Farah H. Abdalbari et al, 2023, Cancers CrossRef
12. The emerging role of deubiquitylating enzymes as therapeutic targets in cancer metabolism
    Rongfu Tu et al, 2022, Cancer Cell International CrossRef
13. Biological and computational assessment of new synthesized nicotinamides as potential immunomodulatory VEGFR-2 inhibitors
    Reda G. Yousef et al, 2024, Journal of Molecular Structure CrossRef
14. A novel cyclic dinuclear gold(i) complex induces anticancer activity via an oxidative stress-mediated intrinsic apoptotic pathway in MDA-MB-231 cancer cells
    Ahmed K. Abogosh et al, 2022, Dalton Transactions CrossRef
15. Upgrade of an old drug: Auranofin in innovative cancer therapies to overcome drug resistance and to increase drug effectiveness
    Tania Gamberi et al, 2022, Medicinal Research Reviews CrossRef
16. Anti-Cancer Effects of Auranofin in Human Lung Cancer Cells by Increasing Intracellular ROS Levels and Depleting GSH Levels
    Xia Ying Cui et al, 2022, Molecules CrossRef
17. The synthesis of novel water-soluble zinc (II) phthalocyanine based photosensitizers and exploring of photodynamic therapy activities on the PC3 cancer cell line
    Nagihan Kocaağa et al, 2023, Photochemical & Photobiological Sciences CrossRef
18. Functional utility of gold complexes with phosphorus donor ligands in biological systems
    Adedamola S. Arojojoye et al, 2025, Coordination Chemistry Reviews CrossRef
19. Repurposing auranofin and meclofenamic acid as energy-metabolism inhibitors and anti-cancer drugs
    Sara Rodríguez-Enríquez et al, 2024, PLOS ONE CrossRef
20. Multi-Targeted Anticancer Activity of Imidazolate Phosphane Gold(I) Compounds by Inhibition of DHFR and TrxR in Breast Cancer Cells
    Rossana Galassi et al, 2021, Frontiers in Chemistry CrossRef
21. Synthesis, anticancer activity and apoptosis induction of gold(I) complexes containing tris(o-methoxyphenyl)phosphane
    Adam A.A. Sulaiman et al, 2021, Inorganica Chimica Acta CrossRef